The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply

Shu Su; William CW Wong; Jason J. Ong; Wai Kay Seto; Lei Zhang

doi:10.1016/S2214-109X(22)00165-6

The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply

Shu Su, William CW Wong, Jason J. Ong, Wai Kay Seto, Lei Zhang

Research output: Contribution to journal › Letter › Other › peer-review

Original language	English
Pages (from-to)	e793
Number of pages	1
Journal	The Lancet Global Health
Volume	10
Issue number	6
DOIs	https://doi.org/10.1016/S2214-109X(22)00165-6
Publication status	Published - Jun 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2214-109X(22)00165-6Licence: CC BY

380865422-oaFinal published version, 38.4 KBLicence: CC BY

Cite this

@article{ce481fe36daf43c8bdfdce3a637c5b84,

title = "The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply",

author = "Shu Su and Wong, {William CW} and Ong, {Jason J.} and Seto, {Wai Kay} and Lei Zhang",

year = "2022",

month = jun,

doi = "10.1016/S2214-109X(22)00165-6",

language = "English",

volume = "10",

pages = "e793",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "The Lancet Publishing Group",

number = "6",

}

TY - JOUR

T1 - The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply

AU - Su, Shu

AU - Wong, William CW

AU - Ong, Jason J.

AU - Seto, Wai Kay

AU - Zhang, Lei

PY - 2022/6

Y1 - 2022/6

UR - http://www.scopus.com/inward/record.url?scp=85129562759&partnerID=8YFLogxK

U2 - 10.1016/S2214-109X(22)00165-6

DO - 10.1016/S2214-109X(22)00165-6

M3 - Letter

C2 - 35561714

AN - SCOPUS:85129562759

SN - 2214-109X

VL - 10

SP - e793

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 6

ER -

The optimal screening strategy for chronic hepatitis B virus infection in China – Authors' reply

UN SDGs

Access to Document

Other files and links

Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation

Cite this